nodes	percent_of_prediction	percent_of_DWPC	metapath
Clarithromycin—SLC22A7—Fluorouracil—pancreatic cancer	0.0803	0.103	CbGbCtD
Clarithromycin—SLC22A7—Docetaxel—pancreatic cancer	0.0613	0.079	CbGbCtD
Clarithromycin—CYP3A7—Tamoxifen—pancreatic cancer	0.0423	0.0545	CbGbCtD
Clarithromycin—CYP3A7-CYP3A51P—Tamoxifen—pancreatic cancer	0.0423	0.0545	CbGbCtD
Clarithromycin—CYP3A7—Irinotecan—pancreatic cancer	0.0325	0.0418	CbGbCtD
Clarithromycin—CYP3A7-CYP3A51P—Irinotecan—pancreatic cancer	0.0325	0.0418	CbGbCtD
Clarithromycin—CYP3A5—Tamoxifen—pancreatic cancer	0.0317	0.0409	CbGbCtD
Clarithromycin—CYP1A2—Dacarbazine—pancreatic cancer	0.0297	0.0382	CbGbCtD
Clarithromycin—CYP3A5—Erlotinib—pancreatic cancer	0.027	0.0348	CbGbCtD
Clarithromycin—CYP2C19—Tamoxifen—pancreatic cancer	0.0256	0.033	CbGbCtD
Clarithromycin—CYP3A5—Irinotecan—pancreatic cancer	0.0244	0.0314	CbGbCtD
Clarithromycin—CYP3A7—Docetaxel—pancreatic cancer	0.0238	0.0307	CbGbCtD
Clarithromycin—CYP3A7-CYP3A51P—Docetaxel—pancreatic cancer	0.0238	0.0307	CbGbCtD
Clarithromycin—CYP3A7—Sunitinib—pancreatic cancer	0.0237	0.0305	CbGbCtD
Clarithromycin—CYP3A7-CYP3A51P—Sunitinib—pancreatic cancer	0.0237	0.0305	CbGbCtD
Clarithromycin—CYP1A2—Tamoxifen—pancreatic cancer	0.0236	0.0304	CbGbCtD
Clarithromycin—ABCB1—Tamoxifen—pancreatic cancer	0.0206	0.0266	CbGbCtD
Clarithromycin—CYP1A2—Erlotinib—pancreatic cancer	0.0201	0.0259	CbGbCtD
Clarithromycin—CYP3A5—Docetaxel—pancreatic cancer	0.0178	0.023	CbGbCtD
Clarithromycin—ABCB1—Gemcitabine—pancreatic cancer	0.0178	0.0229	CbGbCtD
Clarithromycin—CYP3A5—Sunitinib—pancreatic cancer	0.0178	0.0229	CbGbCtD
Clarithromycin—ABCB1—Erlotinib—pancreatic cancer	0.0175	0.0226	CbGbCtD
Clarithromycin—CYP1A2—Fluorouracil—pancreatic cancer	0.0174	0.0224	CbGbCtD
Clarithromycin—ABCB1—Irinotecan—pancreatic cancer	0.0158	0.0204	CbGbCtD
Clarithromycin—CYP3A4—Tamoxifen—pancreatic cancer	0.0124	0.0159	CbGbCtD
Clarithromycin—ABCB1—Docetaxel—pancreatic cancer	0.0116	0.015	CbGbCtD
Clarithromycin—ABCB1—Sunitinib—pancreatic cancer	0.0116	0.0149	CbGbCtD
Clarithromycin—CYP3A4—Erlotinib—pancreatic cancer	0.0105	0.0136	CbGbCtD
Clarithromycin—CYP3A4—Irinotecan—pancreatic cancer	0.0095	0.0122	CbGbCtD
Clarithromycin—ABCB1—Doxorubicin—pancreatic cancer	0.00866	0.0112	CbGbCtD
Clarithromycin—CYP3A4—Docetaxel—pancreatic cancer	0.00696	0.00897	CbGbCtD
Clarithromycin—CYP3A4—Sunitinib—pancreatic cancer	0.00693	0.00893	CbGbCtD
Clarithromycin—CYP3A4—Doxorubicin—pancreatic cancer	0.00519	0.00669	CbGbCtD
Clarithromycin—Influenza—Doxorubicin—pancreatic cancer	0.000138	0.000617	CcSEcCtD
Clarithromycin—Leukopenia—Docetaxel—pancreatic cancer	0.000138	0.000617	CcSEcCtD
Clarithromycin—Body temperature increased—Fluorouracil—pancreatic cancer	0.000138	0.000616	CcSEcCtD
Clarithromycin—Eosinophilia—Doxorubicin—pancreatic cancer	0.000137	0.000611	CcSEcCtD
Clarithromycin—Palpitations—Docetaxel—pancreatic cancer	0.000137	0.000609	CcSEcCtD
Clarithromycin—Loss of consciousness—Docetaxel—pancreatic cancer	0.000136	0.000606	CcSEcCtD
Clarithromycin—Pancreatitis—Doxorubicin—pancreatic cancer	0.000136	0.000605	CcSEcCtD
Clarithromycin—Cough—Docetaxel—pancreatic cancer	0.000135	0.000601	CcSEcCtD
Clarithromycin—Hypersensitivity—Irinotecan—pancreatic cancer	0.000134	0.000599	CcSEcCtD
Clarithromycin—Pneumonia—Epirubicin—pancreatic cancer	0.000134	0.000598	CcSEcCtD
Clarithromycin—Convulsion—Docetaxel—pancreatic cancer	0.000134	0.000597	CcSEcCtD
Clarithromycin—Infestation NOS—Epirubicin—pancreatic cancer	0.000133	0.000595	CcSEcCtD
Clarithromycin—Infestation—Epirubicin—pancreatic cancer	0.000133	0.000595	CcSEcCtD
Clarithromycin—Stevens-Johnson syndrome—Epirubicin—pancreatic cancer	0.000132	0.00059	CcSEcCtD
Clarithromycin—Chest pain—Docetaxel—pancreatic cancer	0.000132	0.000587	CcSEcCtD
Clarithromycin—Myalgia—Docetaxel—pancreatic cancer	0.000132	0.000587	CcSEcCtD
Clarithromycin—Nausea—Sunitinib—pancreatic cancer	0.000132	0.000587	CcSEcCtD
Clarithromycin—Renal failure—Epirubicin—pancreatic cancer	0.000131	0.000585	CcSEcCtD
Clarithromycin—Asthenia—Irinotecan—pancreatic cancer	0.000131	0.000584	CcSEcCtD
Clarithromycin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000131	0.000583	CcSEcCtD
Clarithromycin—Jaundice—Epirubicin—pancreatic cancer	0.00013	0.00058	CcSEcCtD
Clarithromycin—Stomatitis—Epirubicin—pancreatic cancer	0.00013	0.00058	CcSEcCtD
Clarithromycin—Conjunctivitis—Epirubicin—pancreatic cancer	0.00013	0.000578	CcSEcCtD
Clarithromycin—Neutropenia—Doxorubicin—pancreatic cancer	0.000129	0.000577	CcSEcCtD
Clarithromycin—Dysuria—Doxorubicin—pancreatic cancer	0.000129	0.000577	CcSEcCtD
Clarithromycin—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000129	0.000574	CcSEcCtD
Clarithromycin—Dry mouth—Docetaxel—pancreatic cancer	0.000129	0.000574	CcSEcCtD
Clarithromycin—Asthenia—Gemcitabine—pancreatic cancer	0.000127	0.000568	CcSEcCtD
Clarithromycin—Haematuria—Epirubicin—pancreatic cancer	0.000127	0.000567	CcSEcCtD
Clarithromycin—Confusional state—Docetaxel—pancreatic cancer	0.000127	0.000567	CcSEcCtD
Clarithromycin—Hepatobiliary disease—Epirubicin—pancreatic cancer	0.000126	0.000562	CcSEcCtD
Clarithromycin—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000126	0.000562	CcSEcCtD
Clarithromycin—Epistaxis—Epirubicin—pancreatic cancer	0.000126	0.000561	CcSEcCtD
Clarithromycin—Pruritus—Gemcitabine—pancreatic cancer	0.000126	0.000561	CcSEcCtD
Clarithromycin—Infection—Docetaxel—pancreatic cancer	0.000125	0.000559	CcSEcCtD
Clarithromycin—Diarrhoea—Irinotecan—pancreatic cancer	0.000125	0.000557	CcSEcCtD
Clarithromycin—Agranulocytosis—Epirubicin—pancreatic cancer	0.000124	0.000555	CcSEcCtD
Clarithromycin—Pneumonia—Doxorubicin—pancreatic cancer	0.000124	0.000553	CcSEcCtD
Clarithromycin—Nervous system disorder—Docetaxel—pancreatic cancer	0.000124	0.000551	CcSEcCtD
Clarithromycin—Pruritus—Fluorouracil—pancreatic cancer	0.000124	0.000551	CcSEcCtD
Clarithromycin—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000123	0.000551	CcSEcCtD
Clarithromycin—Infestation NOS—Doxorubicin—pancreatic cancer	0.000123	0.00055	CcSEcCtD
Clarithromycin—Infestation—Doxorubicin—pancreatic cancer	0.000123	0.00055	CcSEcCtD
Clarithromycin—Skin disorder—Docetaxel—pancreatic cancer	0.000122	0.000546	CcSEcCtD
Clarithromycin—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	0.000122	0.000546	CcSEcCtD
Clarithromycin—Diarrhoea—Gemcitabine—pancreatic cancer	0.000122	0.000542	CcSEcCtD
Clarithromycin—Renal failure—Doxorubicin—pancreatic cancer	0.000121	0.000541	CcSEcCtD
Clarithromycin—Dizziness—Irinotecan—pancreatic cancer	0.000121	0.000538	CcSEcCtD
Clarithromycin—Haemoglobin—Epirubicin—pancreatic cancer	0.00012	0.000537	CcSEcCtD
Clarithromycin—Stomatitis—Doxorubicin—pancreatic cancer	0.00012	0.000536	CcSEcCtD
Clarithromycin—Jaundice—Doxorubicin—pancreatic cancer	0.00012	0.000536	CcSEcCtD
Clarithromycin—Anorexia—Docetaxel—pancreatic cancer	0.00012	0.000536	CcSEcCtD
Clarithromycin—Rhinitis—Epirubicin—pancreatic cancer	0.00012	0.000535	CcSEcCtD
Clarithromycin—Conjunctivitis—Doxorubicin—pancreatic cancer	0.00012	0.000535	CcSEcCtD
Clarithromycin—Haemorrhage—Epirubicin—pancreatic cancer	0.00012	0.000534	CcSEcCtD
Clarithromycin—Hepatitis—Epirubicin—pancreatic cancer	0.00012	0.000534	CcSEcCtD
Clarithromycin—Diarrhoea—Fluorouracil—pancreatic cancer	0.00012	0.000533	CcSEcCtD
Clarithromycin—Pharyngitis—Epirubicin—pancreatic cancer	0.000119	0.00053	CcSEcCtD
Clarithromycin—Urinary tract disorder—Epirubicin—pancreatic cancer	0.000118	0.000527	CcSEcCtD
Clarithromycin—Haematuria—Doxorubicin—pancreatic cancer	0.000118	0.000525	CcSEcCtD
Clarithromycin—Connective tissue disorder—Epirubicin—pancreatic cancer	0.000118	0.000525	CcSEcCtD
Clarithromycin—Urethral disorder—Epirubicin—pancreatic cancer	0.000117	0.000523	CcSEcCtD
Clarithromycin—Hepatobiliary disease—Doxorubicin—pancreatic cancer	0.000117	0.00052	CcSEcCtD
Clarithromycin—Epistaxis—Doxorubicin—pancreatic cancer	0.000116	0.000519	CcSEcCtD
Clarithromycin—Vomiting—Irinotecan—pancreatic cancer	0.000116	0.000517	CcSEcCtD
Clarithromycin—Dizziness—Fluorouracil—pancreatic cancer	0.000116	0.000515	CcSEcCtD
Clarithromycin—Visual impairment—Epirubicin—pancreatic cancer	0.000115	0.000514	CcSEcCtD
Clarithromycin—Agranulocytosis—Doxorubicin—pancreatic cancer	0.000115	0.000513	CcSEcCtD
Clarithromycin—Rash—Irinotecan—pancreatic cancer	0.000115	0.000513	CcSEcCtD
Clarithromycin—Dermatitis—Irinotecan—pancreatic cancer	0.000115	0.000512	CcSEcCtD
Clarithromycin—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000115	0.000512	CcSEcCtD
Clarithromycin—Headache—Irinotecan—pancreatic cancer	0.000114	0.00051	CcSEcCtD
Clarithromycin—Insomnia—Docetaxel—pancreatic cancer	0.000114	0.000509	CcSEcCtD
Clarithromycin—Paraesthesia—Docetaxel—pancreatic cancer	0.000113	0.000505	CcSEcCtD
Clarithromycin—Erythema multiforme—Epirubicin—pancreatic cancer	0.000113	0.000505	CcSEcCtD
Clarithromycin—Vomiting—Gemcitabine—pancreatic cancer	0.000113	0.000504	CcSEcCtD
Clarithromycin—Dyspnoea—Docetaxel—pancreatic cancer	0.000112	0.000501	CcSEcCtD
Clarithromycin—Somnolence—Docetaxel—pancreatic cancer	0.000112	0.0005	CcSEcCtD
Clarithromycin—Rash—Gemcitabine—pancreatic cancer	0.000112	0.0005	CcSEcCtD
Clarithromycin—Dermatitis—Gemcitabine—pancreatic cancer	0.000112	0.000499	CcSEcCtD
Clarithromycin—Eye disorder—Epirubicin—pancreatic cancer	0.000112	0.000499	CcSEcCtD
Clarithromycin—Tinnitus—Epirubicin—pancreatic cancer	0.000112	0.000498	CcSEcCtD
Clarithromycin—Haemoglobin—Doxorubicin—pancreatic cancer	0.000111	0.000496	CcSEcCtD
Clarithromycin—Headache—Gemcitabine—pancreatic cancer	0.000111	0.000496	CcSEcCtD
Clarithromycin—Flushing—Epirubicin—pancreatic cancer	0.000111	0.000495	CcSEcCtD
Clarithromycin—Cardiac disorder—Epirubicin—pancreatic cancer	0.000111	0.000495	CcSEcCtD
Clarithromycin—Vomiting—Fluorouracil—pancreatic cancer	0.000111	0.000495	CcSEcCtD
Clarithromycin—Rhinitis—Doxorubicin—pancreatic cancer	0.000111	0.000495	CcSEcCtD
Clarithromycin—Dyspepsia—Docetaxel—pancreatic cancer	0.000111	0.000495	CcSEcCtD
Clarithromycin—Haemorrhage—Doxorubicin—pancreatic cancer	0.000111	0.000494	CcSEcCtD
Clarithromycin—Hepatitis—Doxorubicin—pancreatic cancer	0.000111	0.000494	CcSEcCtD
Clarithromycin—Rash—Fluorouracil—pancreatic cancer	0.00011	0.000491	CcSEcCtD
Clarithromycin—Dermatitis—Fluorouracil—pancreatic cancer	0.00011	0.000491	CcSEcCtD
Clarithromycin—Pharyngitis—Doxorubicin—pancreatic cancer	0.00011	0.00049	CcSEcCtD
Clarithromycin—Decreased appetite—Docetaxel—pancreatic cancer	0.00011	0.000489	CcSEcCtD
Clarithromycin—Headache—Fluorouracil—pancreatic cancer	0.000109	0.000488	CcSEcCtD
Clarithromycin—Urinary tract disorder—Doxorubicin—pancreatic cancer	0.000109	0.000488	CcSEcCtD
Clarithromycin—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000109	0.000485	CcSEcCtD
Clarithromycin—Connective tissue disorder—Doxorubicin—pancreatic cancer	0.000109	0.000485	CcSEcCtD
Clarithromycin—Fatigue—Docetaxel—pancreatic cancer	0.000109	0.000485	CcSEcCtD
Clarithromycin—Angiopathy—Epirubicin—pancreatic cancer	0.000109	0.000484	CcSEcCtD
Clarithromycin—Urethral disorder—Doxorubicin—pancreatic cancer	0.000109	0.000484	CcSEcCtD
Clarithromycin—Nausea—Irinotecan—pancreatic cancer	0.000108	0.000483	CcSEcCtD
Clarithromycin—Immune system disorder—Epirubicin—pancreatic cancer	0.000108	0.000482	CcSEcCtD
Clarithromycin—Mediastinal disorder—Epirubicin—pancreatic cancer	0.000108	0.000481	CcSEcCtD
Clarithromycin—Constipation—Docetaxel—pancreatic cancer	0.000108	0.000481	CcSEcCtD
Clarithromycin—Pain—Docetaxel—pancreatic cancer	0.000108	0.000481	CcSEcCtD
Clarithromycin—Chills—Epirubicin—pancreatic cancer	0.000107	0.000479	CcSEcCtD
Clarithromycin—Visual impairment—Doxorubicin—pancreatic cancer	0.000107	0.000476	CcSEcCtD
Clarithromycin—Nausea—Gemcitabine—pancreatic cancer	0.000106	0.000471	CcSEcCtD
Clarithromycin—Mental disorder—Epirubicin—pancreatic cancer	0.000105	0.000468	CcSEcCtD
Clarithromycin—Erythema multiforme—Doxorubicin—pancreatic cancer	0.000105	0.000467	CcSEcCtD
Clarithromycin—Malnutrition—Epirubicin—pancreatic cancer	0.000104	0.000465	CcSEcCtD
Clarithromycin—Feeling abnormal—Docetaxel—pancreatic cancer	0.000104	0.000463	CcSEcCtD
Clarithromycin—Nausea—Fluorouracil—pancreatic cancer	0.000104	0.000463	CcSEcCtD
Clarithromycin—Eye disorder—Doxorubicin—pancreatic cancer	0.000103	0.000462	CcSEcCtD
Clarithromycin—Tinnitus—Doxorubicin—pancreatic cancer	0.000103	0.000461	CcSEcCtD
Clarithromycin—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000103	0.00046	CcSEcCtD
Clarithromycin—Flushing—Doxorubicin—pancreatic cancer	0.000103	0.000458	CcSEcCtD
Clarithromycin—Cardiac disorder—Doxorubicin—pancreatic cancer	0.000103	0.000458	CcSEcCtD
Clarithromycin—Flatulence—Epirubicin—pancreatic cancer	0.000103	0.000458	CcSEcCtD
Clarithromycin—Tension—Epirubicin—pancreatic cancer	0.000102	0.000456	CcSEcCtD
Clarithromycin—Dysgeusia—Epirubicin—pancreatic cancer	0.000102	0.000455	CcSEcCtD
Clarithromycin—Nervousness—Epirubicin—pancreatic cancer	0.000101	0.000451	CcSEcCtD
Clarithromycin—Back pain—Epirubicin—pancreatic cancer	0.000101	0.00045	CcSEcCtD
Clarithromycin—Angiopathy—Doxorubicin—pancreatic cancer	0.0001	0.000448	CcSEcCtD
Clarithromycin—Muscle spasms—Epirubicin—pancreatic cancer	0.0001	0.000447	CcSEcCtD
Clarithromycin—Immune system disorder—Doxorubicin—pancreatic cancer	0.0001	0.000446	CcSEcCtD
Clarithromycin—Mediastinal disorder—Doxorubicin—pancreatic cancer	9.98e-05	0.000445	CcSEcCtD
Clarithromycin—Abdominal pain—Docetaxel—pancreatic cancer	9.97e-05	0.000445	CcSEcCtD
Clarithromycin—Body temperature increased—Docetaxel—pancreatic cancer	9.97e-05	0.000445	CcSEcCtD
Clarithromycin—Chills—Doxorubicin—pancreatic cancer	9.94e-05	0.000443	CcSEcCtD
Clarithromycin—Mental disorder—Doxorubicin—pancreatic cancer	9.7e-05	0.000433	CcSEcCtD
Clarithromycin—Ill-defined disorder—Epirubicin—pancreatic cancer	9.67e-05	0.000431	CcSEcCtD
Clarithromycin—Malnutrition—Doxorubicin—pancreatic cancer	9.64e-05	0.00043	CcSEcCtD
Clarithromycin—Anaemia—Epirubicin—pancreatic cancer	9.63e-05	0.00043	CcSEcCtD
Clarithromycin—Agitation—Epirubicin—pancreatic cancer	9.57e-05	0.000427	CcSEcCtD
Clarithromycin—Flatulence—Doxorubicin—pancreatic cancer	9.5e-05	0.000424	CcSEcCtD
Clarithromycin—Tension—Doxorubicin—pancreatic cancer	9.46e-05	0.000422	CcSEcCtD
Clarithromycin—Dysgeusia—Doxorubicin—pancreatic cancer	9.44e-05	0.000421	CcSEcCtD
Clarithromycin—Malaise—Epirubicin—pancreatic cancer	9.4e-05	0.000419	CcSEcCtD
Clarithromycin—Nervousness—Doxorubicin—pancreatic cancer	9.36e-05	0.000418	CcSEcCtD
Clarithromycin—Vertigo—Epirubicin—pancreatic cancer	9.36e-05	0.000418	CcSEcCtD
Clarithromycin—Leukopenia—Epirubicin—pancreatic cancer	9.33e-05	0.000416	CcSEcCtD
Clarithromycin—Back pain—Doxorubicin—pancreatic cancer	9.33e-05	0.000416	CcSEcCtD
Clarithromycin—Hypersensitivity—Docetaxel—pancreatic cancer	9.29e-05	0.000414	CcSEcCtD
Clarithromycin—Muscle spasms—Doxorubicin—pancreatic cancer	9.27e-05	0.000413	CcSEcCtD
Clarithromycin—Palpitations—Epirubicin—pancreatic cancer	9.21e-05	0.000411	CcSEcCtD
Clarithromycin—Loss of consciousness—Epirubicin—pancreatic cancer	9.16e-05	0.000408	CcSEcCtD
Clarithromycin—Cough—Epirubicin—pancreatic cancer	9.09e-05	0.000406	CcSEcCtD
Clarithromycin—Asthenia—Docetaxel—pancreatic cancer	9.05e-05	0.000403	CcSEcCtD
Clarithromycin—Convulsion—Epirubicin—pancreatic cancer	9.03e-05	0.000403	CcSEcCtD
Clarithromycin—Ill-defined disorder—Doxorubicin—pancreatic cancer	8.94e-05	0.000399	CcSEcCtD
Clarithromycin—Pruritus—Docetaxel—pancreatic cancer	8.92e-05	0.000398	CcSEcCtD
Clarithromycin—Anaemia—Doxorubicin—pancreatic cancer	8.91e-05	0.000397	CcSEcCtD
Clarithromycin—Chest pain—Epirubicin—pancreatic cancer	8.87e-05	0.000396	CcSEcCtD
Clarithromycin—Myalgia—Epirubicin—pancreatic cancer	8.87e-05	0.000396	CcSEcCtD
Clarithromycin—Agitation—Doxorubicin—pancreatic cancer	8.86e-05	0.000395	CcSEcCtD
Clarithromycin—Anxiety—Epirubicin—pancreatic cancer	8.84e-05	0.000394	CcSEcCtD
Clarithromycin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	8.81e-05	0.000393	CcSEcCtD
Clarithromycin—Discomfort—Epirubicin—pancreatic cancer	8.76e-05	0.000391	CcSEcCtD
Clarithromycin—Malaise—Doxorubicin—pancreatic cancer	8.69e-05	0.000388	CcSEcCtD
Clarithromycin—Dry mouth—Epirubicin—pancreatic cancer	8.68e-05	0.000387	CcSEcCtD
Clarithromycin—Vertigo—Doxorubicin—pancreatic cancer	8.66e-05	0.000386	CcSEcCtD
Clarithromycin—Leukopenia—Doxorubicin—pancreatic cancer	8.63e-05	0.000385	CcSEcCtD
Clarithromycin—Diarrhoea—Docetaxel—pancreatic cancer	8.63e-05	0.000385	CcSEcCtD
Clarithromycin—Confusional state—Epirubicin—pancreatic cancer	8.57e-05	0.000382	CcSEcCtD
Clarithromycin—Palpitations—Doxorubicin—pancreatic cancer	8.52e-05	0.00038	CcSEcCtD
Clarithromycin—Anaphylactic shock—Epirubicin—pancreatic cancer	8.5e-05	0.000379	CcSEcCtD
Clarithromycin—Loss of consciousness—Doxorubicin—pancreatic cancer	8.47e-05	0.000378	CcSEcCtD
Clarithromycin—Infection—Epirubicin—pancreatic cancer	8.45e-05	0.000377	CcSEcCtD
Clarithromycin—Cough—Doxorubicin—pancreatic cancer	8.41e-05	0.000375	CcSEcCtD
Clarithromycin—Convulsion—Doxorubicin—pancreatic cancer	8.35e-05	0.000373	CcSEcCtD
Clarithromycin—Nervous system disorder—Epirubicin—pancreatic cancer	8.34e-05	0.000372	CcSEcCtD
Clarithromycin—Dizziness—Docetaxel—pancreatic cancer	8.34e-05	0.000372	CcSEcCtD
Clarithromycin—Thrombocytopenia—Epirubicin—pancreatic cancer	8.33e-05	0.000371	CcSEcCtD
Clarithromycin—Skin disorder—Epirubicin—pancreatic cancer	8.26e-05	0.000368	CcSEcCtD
Clarithromycin—Hyperhidrosis—Epirubicin—pancreatic cancer	8.22e-05	0.000367	CcSEcCtD
Clarithromycin—Myalgia—Doxorubicin—pancreatic cancer	8.21e-05	0.000366	CcSEcCtD
Clarithromycin—Chest pain—Doxorubicin—pancreatic cancer	8.21e-05	0.000366	CcSEcCtD
Clarithromycin—Anxiety—Doxorubicin—pancreatic cancer	8.18e-05	0.000365	CcSEcCtD
Clarithromycin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	8.15e-05	0.000364	CcSEcCtD
Clarithromycin—Discomfort—Doxorubicin—pancreatic cancer	8.11e-05	0.000362	CcSEcCtD
Clarithromycin—Anorexia—Epirubicin—pancreatic cancer	8.11e-05	0.000362	CcSEcCtD
Clarithromycin—Dry mouth—Doxorubicin—pancreatic cancer	8.03e-05	0.000358	CcSEcCtD
Clarithromycin—Vomiting—Docetaxel—pancreatic cancer	8.02e-05	0.000358	CcSEcCtD
Clarithromycin—Rash—Docetaxel—pancreatic cancer	7.95e-05	0.000355	CcSEcCtD
Clarithromycin—Dermatitis—Docetaxel—pancreatic cancer	7.94e-05	0.000354	CcSEcCtD
Clarithromycin—Confusional state—Doxorubicin—pancreatic cancer	7.93e-05	0.000354	CcSEcCtD
Clarithromycin—Headache—Docetaxel—pancreatic cancer	7.9e-05	0.000352	CcSEcCtD
Clarithromycin—Anaphylactic shock—Doxorubicin—pancreatic cancer	7.87e-05	0.000351	CcSEcCtD
Clarithromycin—Infection—Doxorubicin—pancreatic cancer	7.82e-05	0.000349	CcSEcCtD
Clarithromycin—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	7.75e-05	0.000346	CcSEcCtD
Clarithromycin—Nervous system disorder—Doxorubicin—pancreatic cancer	7.72e-05	0.000344	CcSEcCtD
Clarithromycin—Thrombocytopenia—Doxorubicin—pancreatic cancer	7.7e-05	0.000344	CcSEcCtD
Clarithromycin—Insomnia—Epirubicin—pancreatic cancer	7.69e-05	0.000343	CcSEcCtD
Clarithromycin—Skin disorder—Doxorubicin—pancreatic cancer	7.64e-05	0.000341	CcSEcCtD
Clarithromycin—Paraesthesia—Epirubicin—pancreatic cancer	7.64e-05	0.000341	CcSEcCtD
Clarithromycin—Hyperhidrosis—Doxorubicin—pancreatic cancer	7.61e-05	0.000339	CcSEcCtD
Clarithromycin—Dyspnoea—Epirubicin—pancreatic cancer	7.58e-05	0.000338	CcSEcCtD
Clarithromycin—Somnolence—Epirubicin—pancreatic cancer	7.56e-05	0.000337	CcSEcCtD
Clarithromycin—Anorexia—Doxorubicin—pancreatic cancer	7.5e-05	0.000335	CcSEcCtD
Clarithromycin—Nausea—Docetaxel—pancreatic cancer	7.49e-05	0.000334	CcSEcCtD
Clarithromycin—Dyspepsia—Epirubicin—pancreatic cancer	7.49e-05	0.000334	CcSEcCtD
Clarithromycin—Decreased appetite—Epirubicin—pancreatic cancer	7.39e-05	0.00033	CcSEcCtD
Clarithromycin—Gastrointestinal disorder—Epirubicin—pancreatic cancer	7.34e-05	0.000327	CcSEcCtD
Clarithromycin—Fatigue—Epirubicin—pancreatic cancer	7.33e-05	0.000327	CcSEcCtD
Clarithromycin—Constipation—Epirubicin—pancreatic cancer	7.27e-05	0.000324	CcSEcCtD
Clarithromycin—Pain—Epirubicin—pancreatic cancer	7.27e-05	0.000324	CcSEcCtD
Clarithromycin—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	7.17e-05	0.00032	CcSEcCtD
Clarithromycin—Insomnia—Doxorubicin—pancreatic cancer	7.12e-05	0.000317	CcSEcCtD
Clarithromycin—Paraesthesia—Doxorubicin—pancreatic cancer	7.06e-05	0.000315	CcSEcCtD
Clarithromycin—Dyspnoea—Doxorubicin—pancreatic cancer	7.01e-05	0.000313	CcSEcCtD
Clarithromycin—Feeling abnormal—Epirubicin—pancreatic cancer	7.01e-05	0.000313	CcSEcCtD
Clarithromycin—Somnolence—Doxorubicin—pancreatic cancer	6.99e-05	0.000312	CcSEcCtD
Clarithromycin—Gastrointestinal pain—Epirubicin—pancreatic cancer	6.95e-05	0.00031	CcSEcCtD
Clarithromycin—Dyspepsia—Doxorubicin—pancreatic cancer	6.93e-05	0.000309	CcSEcCtD
Clarithromycin—Decreased appetite—Doxorubicin—pancreatic cancer	6.84e-05	0.000305	CcSEcCtD
Clarithromycin—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	6.79e-05	0.000303	CcSEcCtD
Clarithromycin—Fatigue—Doxorubicin—pancreatic cancer	6.78e-05	0.000303	CcSEcCtD
Clarithromycin—Urticaria—Epirubicin—pancreatic cancer	6.76e-05	0.000301	CcSEcCtD
Clarithromycin—Pain—Doxorubicin—pancreatic cancer	6.73e-05	0.0003	CcSEcCtD
Clarithromycin—Constipation—Doxorubicin—pancreatic cancer	6.73e-05	0.0003	CcSEcCtD
Clarithromycin—Abdominal pain—Epirubicin—pancreatic cancer	6.72e-05	0.0003	CcSEcCtD
Clarithromycin—Body temperature increased—Epirubicin—pancreatic cancer	6.72e-05	0.0003	CcSEcCtD
Clarithromycin—Feeling abnormal—Doxorubicin—pancreatic cancer	6.48e-05	0.000289	CcSEcCtD
Clarithromycin—Gastrointestinal pain—Doxorubicin—pancreatic cancer	6.43e-05	0.000287	CcSEcCtD
Clarithromycin—Hypersensitivity—Epirubicin—pancreatic cancer	6.26e-05	0.000279	CcSEcCtD
Clarithromycin—Urticaria—Doxorubicin—pancreatic cancer	6.25e-05	0.000279	CcSEcCtD
Clarithromycin—Body temperature increased—Doxorubicin—pancreatic cancer	6.22e-05	0.000277	CcSEcCtD
Clarithromycin—Abdominal pain—Doxorubicin—pancreatic cancer	6.22e-05	0.000277	CcSEcCtD
Clarithromycin—Asthenia—Epirubicin—pancreatic cancer	6.1e-05	0.000272	CcSEcCtD
Clarithromycin—Pruritus—Epirubicin—pancreatic cancer	6.02e-05	0.000268	CcSEcCtD
Clarithromycin—Diarrhoea—Epirubicin—pancreatic cancer	5.82e-05	0.000259	CcSEcCtD
Clarithromycin—Hypersensitivity—Doxorubicin—pancreatic cancer	5.8e-05	0.000259	CcSEcCtD
Clarithromycin—Asthenia—Doxorubicin—pancreatic cancer	5.65e-05	0.000252	CcSEcCtD
Clarithromycin—Dizziness—Epirubicin—pancreatic cancer	5.62e-05	0.000251	CcSEcCtD
Clarithromycin—Pruritus—Doxorubicin—pancreatic cancer	5.57e-05	0.000248	CcSEcCtD
Clarithromycin—Vomiting—Epirubicin—pancreatic cancer	5.41e-05	0.000241	CcSEcCtD
Clarithromycin—Diarrhoea—Doxorubicin—pancreatic cancer	5.38e-05	0.00024	CcSEcCtD
Clarithromycin—Rash—Epirubicin—pancreatic cancer	5.36e-05	0.000239	CcSEcCtD
Clarithromycin—Dermatitis—Epirubicin—pancreatic cancer	5.36e-05	0.000239	CcSEcCtD
Clarithromycin—Headache—Epirubicin—pancreatic cancer	5.33e-05	0.000238	CcSEcCtD
Clarithromycin—Dizziness—Doxorubicin—pancreatic cancer	5.2e-05	0.000232	CcSEcCtD
Clarithromycin—Nausea—Epirubicin—pancreatic cancer	5.05e-05	0.000225	CcSEcCtD
Clarithromycin—Vomiting—Doxorubicin—pancreatic cancer	5e-05	0.000223	CcSEcCtD
Clarithromycin—Rash—Doxorubicin—pancreatic cancer	4.96e-05	0.000221	CcSEcCtD
Clarithromycin—Dermatitis—Doxorubicin—pancreatic cancer	4.96e-05	0.000221	CcSEcCtD
Clarithromycin—Headache—Doxorubicin—pancreatic cancer	4.93e-05	0.00022	CcSEcCtD
Clarithromycin—Nausea—Doxorubicin—pancreatic cancer	4.67e-05	0.000208	CcSEcCtD
